Annual Current Liabilities
$104.50 M
+$32.01 M+44.16%
December 31, 2023
Summary
- As of February 7, 2025, CORT annual total current liabilities is $104.50 million, with the most recent change of +$32.01 million (+44.16%) on December 31, 2023.
- During the last 3 years, CORT annual current liabilities has risen by +$57.01 million (+120.04%).
- CORT annual current liabilities is now at all-time high.
Performance
CORT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$126.22 M
+$25.47 M+25.28%
September 30, 2024
Summary
- As of February 7, 2025, CORT quarterly total current liabilities is $126.22 million, with the most recent change of +$25.47 million (+25.28%) on September 30, 2024.
- Over the past year, CORT quarterly current liabilities has increased by +$29.01 million (+29.85%).
- CORT quarterly current liabilities is now at all-time high.
Performance
CORT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CORT Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.2% | +29.9% |
| 3 y3 years | +120.0% | +74.1% |
| 5 y5 years | +193.8% | +74.1% |
CORT Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +119.8% | at high | +165.5% |
| 5 y | 5-year | at high | +169.1% | at high | +270.4% |
| alltime | all time | at high | +5629.4% | at high | +9909.2% |
Corcept Therapeutics Incorporated Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $126.22 M(+25.3%) |
| Jun 2024 | - | $100.75 M(+3.7%) |
| Mar 2024 | - | $97.20 M(-7.0%) |
| Dec 2023 | $104.50 M(+44.2%) | $104.50 M(-14.3%) |
| Sep 2023 | - | $121.87 M(+31.0%) |
| Jun 2023 | - | $93.06 M(+18.0%) |
| Mar 2023 | - | $78.86 M(+8.8%) |
| Dec 2022 | $72.49 M(+52.5%) | $72.49 M(+36.6%) |
| Sep 2022 | - | $53.07 M(+8.2%) |
| Jun 2022 | - | $49.06 M(-14.3%) |
| Mar 2022 | - | $57.24 M(+20.4%) |
| Dec 2021 | $47.54 M(+0.1%) | $47.54 M(+6.2%) |
| Sep 2021 | - | $44.76 M(-1.4%) |
| Jun 2021 | - | $45.40 M(+11.8%) |
| Mar 2021 | - | $40.60 M(-14.5%) |
| Dec 2020 | $47.49 M(+22.3%) | $47.49 M(+10.3%) |
| Sep 2020 | - | $43.05 M(+1.9%) |
| Jun 2020 | - | $42.24 M(+24.0%) |
| Mar 2020 | - | $34.08 M(-12.3%) |
| Dec 2019 | $38.84 M(+9.2%) | $38.84 M(+19.9%) |
| Sep 2019 | - | $32.40 M(+6.6%) |
| Jun 2019 | - | $30.38 M(-11.2%) |
| Mar 2019 | - | $34.22 M(-3.8%) |
| Dec 2018 | $35.57 M(+20.3%) | $35.57 M(-11.5%) |
| Sep 2018 | - | $40.21 M(+30.2%) |
| Jun 2018 | - | $30.87 M(+11.3%) |
| Mar 2018 | - | $27.75 M(-6.2%) |
| Dec 2017 | $29.57 M(+8.0%) | $29.57 M(+21.3%) |
| Sep 2017 | - | $24.37 M(+19.5%) |
| Jun 2017 | - | $20.39 M(-20.8%) |
| Mar 2017 | - | $25.76 M(-5.9%) |
| Dec 2016 | $27.37 M(+31.1%) | $27.37 M(-13.6%) |
| Sep 2016 | - | $31.68 M(+15.5%) |
| Jun 2016 | - | $27.43 M(+14.2%) |
| Mar 2016 | - | $24.02 M(+15.1%) |
| Dec 2015 | $20.88 M(+54.0%) | $20.88 M(+11.2%) |
| Sep 2015 | - | $18.77 M(+7.7%) |
| Jun 2015 | - | $17.43 M(+12.3%) |
| Mar 2015 | - | $15.53 M(+14.5%) |
| Dec 2014 | $13.55 M | $13.55 M(+8.6%) |
| Sep 2014 | - | $12.49 M(-6.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $13.30 M(-12.7%) |
| Mar 2014 | - | $15.24 M(+19.7%) |
| Dec 2013 | $12.74 M(+52.4%) | $12.74 M(+25.6%) |
| Sep 2013 | - | $10.14 M(+11.7%) |
| Jun 2013 | - | $9.08 M(+10.1%) |
| Mar 2013 | - | $8.24 M(-1.4%) |
| Dec 2012 | $8.36 M(+66.3%) | $8.36 M(+50.7%) |
| Sep 2012 | - | $5.55 M(-4.6%) |
| Jun 2012 | - | $5.82 M(+62.9%) |
| Mar 2012 | - | $3.57 M(-29.0%) |
| Dec 2011 | $5.03 M(+30.2%) | $5.03 M(+85.3%) |
| Sep 2011 | - | $2.71 M(-29.6%) |
| Jun 2011 | - | $3.86 M(+20.7%) |
| Mar 2011 | - | $3.20 M(-17.2%) |
| Dec 2010 | $3.86 M(+59.6%) | $3.86 M(+35.0%) |
| Jun 2010 | - | $2.86 M(+33.4%) |
| Mar 2010 | - | $2.14 M(-11.4%) |
| Dec 2009 | $2.42 M(-15.5%) | $2.42 M(+2.6%) |
| Sep 2009 | - | $2.36 M(+10.3%) |
| Jun 2009 | - | $2.14 M(-34.9%) |
| Mar 2009 | - | $3.28 M(+14.7%) |
| Dec 2008 | $2.86 M(-4.4%) | $2.86 M(-12.9%) |
| Sep 2008 | - | $3.29 M(+71.4%) |
| Jun 2008 | - | $1.92 M(-17.0%) |
| Mar 2008 | - | $2.31 M(-22.9%) |
| Dec 2007 | $2.99 M(-14.8%) | $2.99 M(+12.4%) |
| Sep 2007 | - | $2.66 M(+87.5%) |
| Jun 2007 | - | $1.42 M(-35.3%) |
| Mar 2007 | - | $2.19 M(-37.5%) |
| Dec 2006 | $3.51 M(-0.2%) | $3.51 M(-37.7%) |
| Sep 2006 | - | $5.64 M(+9.1%) |
| Jun 2006 | - | $5.17 M(-0.5%) |
| Mar 2006 | - | $5.20 M(+47.5%) |
| Dec 2005 | $3.52 M(+93.0%) | $3.52 M(+32.6%) |
| Sep 2005 | - | $2.66 M(+76.7%) |
| Jun 2005 | - | $1.50 M(+19.2%) |
| Mar 2005 | - | $1.26 M(-30.9%) |
| Dec 2004 | $1.82 M | $1.82 M(+11.6%) |
| Sep 2004 | - | $1.63 M(+16.7%) |
| Jun 2004 | - | $1.40 M(-8.4%) |
| Mar 2004 | - | $1.53 M |
FAQ
- What is Corcept Therapeutics Incorporated annual total current liabilities?
- What is the all time high annual current liabilities for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual current liabilities year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly current liabilities year-on-year change?
What is Corcept Therapeutics Incorporated annual total current liabilities?
The current annual current liabilities of CORT is $104.50 M
What is the all time high annual current liabilities for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual total current liabilities is $104.50 M
What is Corcept Therapeutics Incorporated annual current liabilities year-on-year change?
Over the past year, CORT annual total current liabilities has changed by +$32.01 M (+44.16%)
What is Corcept Therapeutics Incorporated quarterly total current liabilities?
The current quarterly current liabilities of CORT is $126.22 M
What is the all time high quarterly current liabilities for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly total current liabilities is $126.22 M
What is Corcept Therapeutics Incorporated quarterly current liabilities year-on-year change?
Over the past year, CORT quarterly total current liabilities has changed by +$29.01 M (+29.85%)